2019 President’s Award Finalists: Innovation
Each year, Northwell’s President’s Awards recognize team members who not only surpass our expectations and standards of excellence, but also those who drive innovative business outcomes.
The Innovation award recognizes team members who were finalists in the Innovation Challenge. Northwell’s Innovation Challenge empowers team members to come up with the next big health care innovation in areas such as revenue through new or existing channels, improve patient experience, improve quality of care, positively impact health outcomes and so much more. As an organization, we understand that our people are the ones who bring our patient care to the next level, and this program gives them an opportunity to share their big ideas. Meet this year’s finalists.
AccuLABeler
AccuLABeler represents a proprietary middle-ware solution that interfaces with existing robotics machinery and a lab information system (LIS) to more efficiently relabel tubes referred to the lab for analysis from non-system sources. At Northwell, the current workflow requires 12 FTEs who perform accessioning and relabeling of these tubes. The total available market encompasses reference laboratories in the United States and abroad.
Bedside Voice Assistant
The Bedside Voice Assistant (BVA) involves the continued development of an existing prototype of a bed-side Alexa based voice assistant created by members of the Northwell Innovation Center. This innovation represents a developed software product which is cloud based, HIPAA compliant and will be agnostic to EMR system for integration and scalability.
EDCAP aza-Peptide Building Blocks for Preferred Drug Characteristics
Many pharmaceutical drugs are peptides, small fragments of proteins. When carefully chosen, peptides offer the advantage of selectivity toward a target coupled with minimal adverse side effects. However, peptides suffer from a very short half-life, and their effect can be very short lived because they are destroyed in seconds in the blood. The EDCAP technology offers a general solution to this stability issue through changing the labile peptide bond to an alternate bond that is resistant to peptidases (stable for hours in the blood).
LabFly: Mobile Phlebotomy App
The proposed innovation reflects the development of a mobile blood drawing solution for patients and caregivers. As developed, LabFly would serve as the patient facing application, and integrate with LabFly Phleb, a phlebotomist facing application. The applications have been reviewed by the Northwell OCIO, OCIO security review, penetration tests and a QM validation. Future development of the application could support on demand appointments for flu shots and strep testing, and/or integration with care delivery within emergency rooms.
Real-Time Actionable Data (RAD)
The RAD invention represents a data analysis and reporting tool which provides real time, actionable data related to ED utilization and the allocation of clinical resources. RAD addresses an unmet need in many if not all emergency rooms by supporting data driven, patient specific, decision making. This product builds upon the work conducted over the past several years within the Northwell Emergency Medicine service line.
Subscribe to our blogs
Stay up to date with stories you want to know more about right to your email inbox.
